Research location
Cypress
California, United States
Advertisement
Research activity in Cypress
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 58 trials and 58 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cypress
58 linked trials · page 1 of 2A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body WeightNCT07710768 · 2026-07-15 · 1 site observation
RECRUITING
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityNCT07395687 · 2026-02-02 · 1 site observation
RECRUITING
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671NCT07815678 · 2025-12-29 · 1 site observation
RECRUITING
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)NCT07225816 · 2025-11-07 · 1 site observation
RECRUITING
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without DiabetesNCT06924320 · 2025-03-06 · 1 site observation
RECRUITING
A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or ObesityNCT07101783 · 2025-08-01 · 1 site observation
COMPLETED
A Study of MET233 in Individuals With Obesity or OverweightNCT07022977 · 2024-11-06 · 1 site observation
COMPLETED
A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian MenNCT06542536 · 2024-08-09 · 1 site observation
COMPLETED
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or ObesityNCT06857617 · 2024-04-01 · 1 site observation
COMPLETED
A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) DoseNCT05689099 · 2023-01-17 · 1 site observation
COMPLETED
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's DiseaseNCT05644977 · 2022-12-02 · 1 site observation
COMPLETED
A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled HypertensionNCT05314439 · 2022-04-29 · 1 site observation
COMPLETED
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy PeopleNCT05227196 · 2022-02-04 · 1 site observation
COMPLETED
A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy ParticipantsNCT04451408 · 2020-07-07 · 1 site observation
COMPLETED
Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy IndividualsNCT04207840 · 2019-12-09 · 1 site observation
COMPLETED
PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPDNCT03307512 · 2018-02-06 · 1 site observation
TERMINATED
Study of REGN3500 and Dupilumab in Patients With AsthmaNCT03112577 · 2017-06-15 · 1 site observation
COMPLETED
Study With Healthy Japanese and Non-Asian Participants With BMS-986231NCT02932969 · 2016-10-04 · 1 site observation
COMPLETED
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)NCT02537938 · 2016-01-01 · 1 site observation
COMPLETED
Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive ImpairmentNCT02573740 · 2015-12-01 · 1 site observation
TERMINATED
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)NCT02534480 · 2015-03-01 · 1 site observation
COMPLETED
Evaluation of Pharmacokinetics and Safety of A006 in Healthy VolunteersNCT02271334 · 2014-08-01 · 1 site observation
COMPLETED
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaNCT02139644 · 2014-06-01 · 1 site observation
COMPLETED
Single Ascending Dose Study of TRN-157 in Healthy SubjectsNCT02133339 · 2014-05-01 · 1 site observation
COMPLETED
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsNCT04474405 · 2013-08-16 · 1 site observation
COMPLETED
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.NCT01928368 · 2013-08-01 · 1 site observation
COMPLETED
Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy AdultsNCT01737892 · 2012-11-01 · 1 site observation
TERMINATED
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With AsthmaNCT01737905 · 2012-10-01 · 1 site observation
COMPLETED
Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive HypertensionNCT01681576 · 2012-08-01 · 1 site observation
COMPLETED
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mLNCT01544348 · 2012-01-01 · 1 site observation
COMPLETED
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese SubjectsNCT01332565 · 2011-04-01 · 1 site observation
COMPLETED
Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICSNCT01255709 · 2010-12-01 · 1 site observation
COMPLETED
Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of PharmacokineticsNCT01188577 · 2010-08-01 · 1 site observation
COMPLETED
Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric SubjectsNCT01453296 · 2010-08-01 · 1 site observation
COMPLETED
Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic PatientsNCT01332292 · 2010-05-01 · 1 site observation
COMPLETED
Safety Study of Nebulized RNS60 to Treat Asthma.NCT01057498 · 2010-05-01 · 1 site observation
COMPLETED
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163NCT01079819 · 2010-04-01 · 1 site observation
COMPLETED
BI 671800 ED in Steroid-naive Asthmatic PatientsNCT01092143 · 2010-03-18 · 1 site observation
COMPLETED
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With AsthmaNCT01103037 · 2010-03-01 · 1 site observation
TERMINATED
Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) AxisNCT01086410 · 2010-03-01 · 1 site observation
COMPLETED
Efficacy, Safety and Pharmacokinetics of Different Regimens of IndacaterolNCT01156844 · 2010-03-01 · 1 site observation
COMPLETED
A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes MellitusNCT01044537 · 2010-02-01 · 1 site observation
COMPLETED
A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329NCT00934089 · 2010-01-01 · 1 site observation
COMPLETED
Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy VolunteersNCT01143051 · 2010-01-01 · 1 site observation
COMPLETED
Safety of Liraglutide in Pediatric Patients With Type 2 DiabetesNCT00943501 · 2009-11-01 · 1 site observation
COMPLETED
Efficacy and Safety Study in Subjects With AsthmaNCT00980200 · 2009-09-01 · 1 site observation
COMPLETED
Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable AsthmaNCT00995904 · 2009-09-01 · 1 site observation
COMPLETED
Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy ParticipantsNCT00833482 · 2009-09-01 · 1 site observation
COMPLETED
A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent AsthmaNCT00946569 · 2009-08-01 · 1 site observation
COMPLETED
Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic PatientsNCT00935220 · 2009-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.